Stocks and Investing
Stocks and Investing
Tue, April 25, 2023
Mon, April 24, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Emmanuel Papadakis Maintained (BNTX) at Hold with Decreased Target to $135 on, Apr 24th, 2023
Emmanuel Papadakis of Deutsche Bank, Maintained "BioNTech SE" (BNTX) at Hold with Decreased Target from $160 to $135 on, Apr 24th, 2023.
Emmanuel has made no other calls on BNTX in the last 4 months.
There are 9 other peers that have a rating on BNTX. Out of the 9 peers that are also analyzing BNTX, 6 agree with Emmanuel's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $128 on, Monday, April 10th, 2023
- Eliana Merle of "UBS" Maintained at Hold with Decreased Target to $153 on, Friday, March 31st, 2023
- Yaron Werber of "TD Cowen" Maintained at Hold with Decreased Target to $130 on, Tuesday, March 28th, 2023
- Matthew Korn of "Morgan Stanley" Maintained at Hold with Decreased Target to $150 on, Tuesday, March 28th, 2023
- Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $140 on, Tuesday, March 28th, 2023
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $216 on, Tuesday, January 24th, 2023
These are the ratings of the 3 analyists that currently disagree with Emmanuel
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $210 on, Thursday, March 30th, 2023
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Decreased Target to $194 on, Tuesday, March 28th, 2023
- Bill Selesky of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $203 on, Tuesday, March 28th, 2023
Contributing Sources